OLVION: Uses, Dosage & Side Effects

A prescription-only oral medicine supplied as 50 mg film-coated tablets for use under the direct supervision of a qualified healthcare professional

Rx Film-coated tablet 50 mg
Active Ingredient
Olvion
Available Forms
Film-coated tablet
Strength
50 mg
Route of Administration
Oral

OLVION is a prescription-only oral medicine supplied as 50 mg film-coated tablets. It is prescribed by a qualified healthcare professional for a specific medical condition and is taken under individualised medical supervision. The film-coated tablet format is designed to be swallowed whole with water, improving palatability and protecting the active ingredient during transit through the stomach. Because OLVION is dispensed only on a valid prescription, the exact indication, dose, duration of treatment and monitoring plan are determined by your doctor based on your personal diagnosis, medical history, other medications and individual risk profile. This guide explains what patients typically need to know about OLVION — how to take it safely, what to watch for, when to seek help and how to get the most out of your treatment — while always referring you back to the Patient Information Leaflet (PIL) supplied with each pack and to the healthcare professionals who know your case.

Quick Facts: OLVION

Active Ingredient
Olvion
Drug Class
See prescriber / PIL
Strength
50 mg
Common Uses
As prescribed
Available Forms
Film-coated tablet
Prescription Status
Rx Only

Key Takeaways

  • OLVION is a prescription-only (Rx) oral medicine in the form of 50 mg film-coated tablets, meaning it can only be obtained with a valid prescription from a licensed doctor and must be used exactly as directed.
  • The film coating is designed to protect the active ingredient, mask taste and improve swallowing comfort; tablets should usually be swallowed whole with water and not crushed, chewed or split unless your doctor or pharmacist specifically advises it.
  • Before starting OLVION, tell your doctor about all existing medical conditions (including kidney, liver and heart problems), any allergies, pregnancy or breastfeeding, and every other medicine, vitamin or herbal supplement you currently take.
  • Do not change the dose, skip doses, stop the medicine early or share OLVION with anyone else, even if they appear to have similar symptoms; doing so can be ineffective or harmful.
  • The Patient Information Leaflet (PIL) inside each pack is the single most authoritative source of information for your specific batch of OLVION — read it fully before your first dose and keep it for reference throughout treatment.

What Is OLVION and What Is It Used For?

Quick Answer: OLVION is a prescription oral medicine supplied as 50 mg film-coated tablets. It is used only for the specific medical indication for which your doctor has prescribed it. Because OLVION requires a prescription, the exact condition it treats, the treatment goals, and the expected response are determined individually by a qualified clinician based on your diagnosis, medical history and personal circumstances.

OLVION belongs to the broad class of oral prescription medicines that are formulated as film-coated tablets. A film-coated tablet consists of a compressed core containing the active substance (olvion, 50 mg per tablet) together with pharmaceutical excipients that support manufacturing, stability and absorption, all surrounded by a thin polymer film. The film coating serves several important purposes: it protects the active ingredient from moisture, light and oxygen; it masks any unpleasant taste or smell; it makes the tablet easier to swallow; and, in some cases, it is designed to disintegrate only after the tablet has passed the stomach, thereby protecting the drug from gastric acid or protecting the stomach lining from the drug.

Prescription medicines such as OLVION are subject to strict regulatory evaluation before they are made available to patients. In the European Union, the Summary of Product Characteristics (SmPC) — authorised by the European Medicines Agency (EMA) or the national competent authority — is the legally binding document that describes the approved indication, dosing, contraindications and safety information. In the United States, the equivalent document is the FDA prescribing information (also known as the “label”). In the United Kingdom, the British National Formulary (BNF) provides a concise, authoritative summary used by clinicians in daily practice. For any given pack of OLVION, the Patient Information Leaflet (PIL) is the patient-facing counterpart to these documents and should be treated as the most reliable point of reference.

Because OLVION is prescription-only, it is not intended for self-diagnosis or self-treatment. Your doctor will confirm that OLVION is appropriate for your specific medical condition only after a complete assessment, which typically includes review of symptoms, clinical examination, relevant laboratory tests or imaging, and consideration of alternative treatment options. This assessment is essential because the same active ingredient can have very different indications, contraindications and dosing schedules depending on the condition being treated and the characteristics of the patient (age, weight, kidney function, liver function, other illnesses, pregnancy status and more).

The 50 mg strength of OLVION represents a single dosing unit. Depending on the prescribed regimen, a patient may take one or more tablets per day, at fixed intervals, with or without food, and for a defined duration. Some conditions are treated with short, fixed-duration courses of therapy (for example, a few days or weeks), while others require long-term or even lifelong treatment with regular clinical and laboratory monitoring. Your doctor or pharmacist will explain exactly how OLVION fits into your overall treatment plan.

It is important to understand that OLVION is not a substitute for general healthy behaviours or for other elements of your care plan. In most chronic conditions, the best outcomes are achieved when medication is combined with appropriate lifestyle measures (such as balanced nutrition, regular physical activity, adequate sleep, smoking cessation and moderation of alcohol intake) and with any non-pharmacological treatments recommended by your clinician. Medicines, including OLVION, work best when integrated into a broader, personalised plan — not when used in isolation.

Where to Find Official Information

For the most accurate, up-to-date information about OLVION that is specific to your country and to the exact product you have been dispensed, always refer to the Patient Information Leaflet (PIL) inside the pack, to the Summary of Product Characteristics (SmPC) published by your national medicines authority, and to your prescribing doctor and community pharmacist. This iMedic guide provides general educational context and does not replace those primary sources.

What Should You Know Before Taking OLVION?

Quick Answer: Do not take OLVION if you are allergic to olvion or any other ingredient in the tablet. Before starting treatment, tell your doctor about all medical conditions, allergies and medicines you take. Discuss pregnancy, breastfeeding or plans to become pregnant. Always follow your doctor’s instructions exactly and read the Patient Information Leaflet before your first dose.

Contraindications

The principal contraindication to OLVION is a known hypersensitivity (allergy) to the active substance olvion or to any of the excipients listed in the Patient Information Leaflet supplied with your pack. Hypersensitivity can range from mild skin reactions to severe, life-threatening anaphylaxis. If you have ever had an allergic reaction to OLVION or to a medicine you believe contained the same active substance, you must inform your doctor before another prescription is issued.

In addition to this general contraindication, individual prescribing information may list further specific contraindications depending on the medical context in which OLVION is used. These can include severe impairment of organs responsible for drug elimination (such as advanced kidney or liver disease), pregnancy at certain stages, concurrent use of particular medicines, or specific genetic conditions. Because these details can change over time as new evidence emerges and as prescribing information is updated, always consult the current Patient Information Leaflet and your prescribing clinician to confirm whether there are additional reasons you should not take OLVION.

Warnings and Precautions

Before starting OLVION, discuss your complete medical history with your doctor. Certain pre-existing conditions may require dose adjustment, more intensive monitoring, or selection of an alternative treatment. Particular categories of patients who should ensure their doctor is fully informed include:

  • Patients with kidney disease: Many oral medicines are partly or wholly cleared by the kidneys. Reduced kidney function can lead to accumulation of the drug and a higher risk of side effects. Your doctor may request a blood test (such as estimated glomerular filtration rate, eGFR) before and during treatment.
  • Patients with liver disease: The liver metabolises many oral medicines. Hepatic impairment may alter drug levels and require dose adjustment. Inform your doctor of any known liver condition, including hepatitis, cirrhosis or abnormal liver function tests.
  • Patients with heart disease: Some medicines can affect heart rhythm, blood pressure or fluid balance. A history of heart failure, arrhythmia, coronary artery disease or uncontrolled hypertension should always be disclosed.
  • Elderly patients: Older adults may be more sensitive to medicines due to age-related changes in organ function, body composition and often the presence of multiple other medications (polypharmacy). Careful assessment is particularly important in this group.
  • Patients with previous serious drug reactions: If you have ever had a major adverse reaction to any medicine, including severe skin reactions, liver injury, blood disorders or anaphylaxis, tell your doctor.
  • Patients with rare hereditary disorders: Some film-coated tablets contain excipients such as lactose or specific colourings. If you have galactose intolerance, total lactase deficiency, glucose-galactose malabsorption or known sensitivity to a specific colouring agent, review the ingredients list in the PIL carefully before starting treatment.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, are planning a pregnancy, or are breastfeeding, consult your doctor before starting OLVION. Prescription medicines vary widely in their safety profile during pregnancy and lactation, and decisions must be made individually. Some medicines are entirely safe, some should be avoided only at certain stages (for example, during the first or third trimester), and some are strictly contraindicated during pregnancy. Similarly, some medicines pass into breast milk in amounts that could affect a nursing infant, while others do not. Your doctor will weigh the benefit of treatment to you against any theoretical or known risk to the baby and recommend the safest approach.

Women of childbearing potential should discuss reliable contraception with their doctor if this is relevant to their treatment plan. If you discover that you are pregnant while taking OLVION, do not stop the medicine abruptly on your own; instead, contact your doctor as soon as possible so that the benefits and risks of continuing can be reassessed.

Driving and Operating Machinery

Some oral medicines can cause drowsiness, dizziness, blurred vision or slowed reactions that might affect your ability to drive a car, operate machinery or work at heights. The effect of OLVION on these abilities depends on the specific indication and on your individual response. When starting a new medicine, it is sensible to avoid driving and operating potentially dangerous equipment until you know how the medicine affects you. If you experience drowsiness, dizziness or other symptoms that could impair performance, do not drive or operate machinery and inform your doctor.

Children and Adolescents

Whether OLVION is suitable for children or adolescents depends entirely on the approved indication and the age-specific data available. Not every adult medicine is appropriate or safe for younger patients. If OLVION has been prescribed for a child or adolescent in your care, ensure that you fully understand how the dose has been calculated (often based on weight or body surface area), how the tablet should be given, and what monitoring is planned. Never give an adult dose of any medicine to a child and do not use a leftover adult prescription to treat a child.

Important Information About Ingredients

Film-coated tablets commonly contain a number of inactive ingredients (excipients) in addition to the active substance. These typically include fillers (such as microcrystalline cellulose or lactose), binders, disintegrants, lubricants and coating components (such as hypromellose, titanium dioxide and colouring agents). The exact excipients in OLVION are listed in the Patient Information Leaflet. If you have any known intolerance or allergy to a pharmaceutical excipient, such as lactose, soy derivatives or a specific dye, review the ingredient list carefully before starting treatment and consult your pharmacist if in doubt.

How Does OLVION Interact with Other Drugs?

Quick Answer: OLVION may interact with other prescription medicines, over-the-counter products, vitamins and herbal supplements. Always give your doctor and pharmacist a complete list of everything you take. Never start or stop a concomitant medicine or supplement during OLVION therapy without first consulting a healthcare professional.

Drug interactions occur when one medicine affects the action of another. They can change the amount of a drug in the body (pharmacokinetic interactions, often involving liver enzymes or transporters), the drug’s effect at its target (pharmacodynamic interactions), or increase the overall risk of side effects. Interactions can occur not only between prescription medicines but also with over-the-counter (OTC) medicines, complementary and herbal products, certain foods and, sometimes, alcohol.

Because OLVION is a prescription medicine, your doctor and pharmacist will screen your existing therapy for relevant interactions at the time of prescribing and dispensing. To enable this, you must provide an accurate, complete list of everything you currently take. Keep a written or digital medicines list and update it whenever something changes. Include:

  • All prescription medicines, including those prescribed by specialists other than your usual doctor.
  • All over-the-counter medicines purchased without a prescription, such as painkillers, anti-inflammatories, antacids, decongestants and laxatives.
  • All vitamins, minerals and dietary supplements.
  • All herbal remedies and traditional medicines, including teas, tinctures and products bought online.
  • Oral contraceptives, hormone replacement therapy and other hormonal products.
  • Any recreational substances, when relevant to safety, as some can interact unpredictably with prescription drugs.

Common categories of medicines that are frequently implicated in drug interactions with oral prescription products are summarised below. This is not an exhaustive list and is intended only to illustrate why a full medication review matters.

General Categories of Medicines That Often Interact with Oral Prescription Drugs
Category Examples Why It Matters
Enzyme inducers Rifampicin, carbamazepine, phenytoin, St John’s wort May lower blood levels of the prescribed drug, reducing effectiveness
Enzyme inhibitors Certain antifungals, macrolide antibiotics, some antiretrovirals, grapefruit juice May raise blood levels of the prescribed drug, increasing side-effect risk
Anticoagulants & antiplatelets Warfarin, apixaban, rivaroxaban, aspirin, clopidogrel Bleeding risk may change when combined with other medicines
CNS depressants Benzodiazepines, opioids, sedative antihistamines, alcohol Additive sedation, slowed breathing or impaired coordination
Drugs affecting heart rhythm Certain antiarrhythmics, some antibiotics, some antipsychotics Possible additive effect on QT interval or arrhythmia risk
Herbal & OTC products St John’s wort, grapefruit juice, high-dose supplements Can meaningfully alter drug levels or enhance side effects
Oral contraceptives Combined and progesterone-only oral contraceptive pills Some medicines reduce contraceptive effectiveness

The above categories are general examples. Whether any particular medicine interacts clinically with OLVION depends on the pharmacology of the active substance, the dose, the duration of treatment and your individual characteristics. Your pharmacist can run a detailed interaction check whenever a new prescription is added to your therapy and can advise whether an alternative medicine, a dose adjustment or additional monitoring is needed.

Tell Your Whole Care Team

If you see more than one clinician (for example, a family doctor, a hospital specialist, a dentist and a mental-health professional), make sure each knows that you are taking OLVION. When possible, use a single pharmacy so that interaction screening covers all of your prescriptions, and always mention over-the-counter and herbal products, which are often overlooked.

What Is the Correct Dosage of OLVION?

Quick Answer: Take OLVION exactly as your doctor has prescribed. Swallow the 50 mg film-coated tablet whole with a full glass of water. Do not change the dose, stop the medicine early, or share it with anyone else. If you are unsure about your schedule, ask your doctor or pharmacist before taking the next dose.

Always take OLVION exactly as your doctor or pharmacist has told you. The prescription label on your pack and the Patient Information Leaflet inside it describe the specific dose, timing and duration that apply to you. Check with your doctor or pharmacist if you are unsure about any aspect of your treatment. The general principles below apply to most oral prescription therapies but do not replace your personalised prescription.

How to Take OLVION

OLVION 50 mg film-coated tablets are for oral use. Swallow each tablet whole with a full glass of water (approximately 200 mL). Do not crush, chew, split or dissolve the tablet in liquid unless your doctor or pharmacist has specifically told you that this is appropriate. Crushing or chewing a film-coated tablet can damage the coating and release the full dose at once, which may reduce effectiveness, increase side effects, or cause irritation to the mouth, throat or stomach.

The question of whether to take OLVION with food, on an empty stomach, in the morning, in the evening, or in relation to other medicines is determined by the pharmacokinetic profile of the active substance and by the indication. Follow the instructions on your prescription and in the PIL. If a particular timing is specified (for example, “take one hour before breakfast” or “take at bedtime”), observe it carefully because it is often important for effectiveness or tolerability.

Adults

The usual adult dose of OLVION is determined by your doctor based on the specific condition being treated, your age, weight, kidney and liver function, other medicines you take and your response to therapy. The 50 mg strength allows for flexible dosing; depending on the prescription, you may be asked to take one tablet per day, more than one tablet per day, or a different schedule tailored to the clinical situation.

OLVION 50 mg: General Dosing Principles by Patient Group
Patient Group General Principle Why It Matters
Adults Dose individualised by prescriber; follow prescription label exactly Ensures balance between effectiveness and side-effect risk
Elderly patients Lower starting dose or slower titration may be used Age-related changes in organ function increase sensitivity
Kidney impairment Dose reduction and/or monitoring often required Reduced clearance can raise drug levels
Liver impairment Dose adjustment may be needed; close monitoring Altered metabolism can change exposure to active substance
Children and adolescents Only if specifically authorised for the age group Safety and effectiveness may differ from adults
Pregnancy & breastfeeding Individual risk–benefit decision with specialist input Fetal and infant safety must be weighed against maternal benefit

Children and Adolescents

Whether OLVION can be used in patients under 18 years of age depends on its approved indication and the data available for pediatric use. If OLVION has been prescribed for a child or adolescent, the dose will have been calculated by a physician based on age and/or body weight. Give the medicine exactly as prescribed, do not adjust the dose without medical advice, and do not use an adult pack to treat a child unless your doctor and pharmacist have explicitly confirmed this is appropriate.

Elderly Patients

Older adults often experience changes in kidney and liver function, body composition and response to medicines, and are more likely to take multiple drugs simultaneously. For these reasons, treatment in elderly patients is often initiated at a lower dose or titrated more slowly. If you or a relative are aged 65 or over, ensure the prescribing doctor is aware of all concurrent medicines and of any issues with swallowing, memory, vision or manual dexterity that might affect safe use of tablets.

Renal and Hepatic Impairment

Dose adjustments for patients with kidney or liver impairment depend on the pharmacology of the active substance in OLVION and on the severity of organ dysfunction. In mild impairment, a standard dose is often suitable; in moderate or severe impairment, the dose may be reduced, the dosing interval extended, or an alternative treatment chosen. Your doctor may request blood tests before and during treatment to assess organ function and to guide any necessary changes.

If You Forget to Take OLVION

If you forget a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your normal schedule. Do not take a double dose to make up for a forgotten one. Using a pill organiser, setting reminders on your phone, or linking the dose to a regular daily activity (such as brushing your teeth) can help prevent missed doses.

If You Stop Taking OLVION

Do not stop taking OLVION earlier than your doctor has instructed, even if you feel better. Stopping a prescription medicine prematurely can allow the underlying condition to return, can allow resistance to develop (for certain drug classes), or can cause withdrawal effects. If you wish to stop treatment for any reason — for example, because of side effects, cost, or life changes — contact your doctor first so that a safe plan can be made. In some cases the dose needs to be reduced gradually rather than stopped abruptly.

If You Take More OLVION Than You Should

If you accidentally take more OLVION than prescribed, contact your doctor, pharmacist, the nearest hospital emergency department, or your local poisons information service immediately. Take the pack, the Patient Information Leaflet, and any remaining tablets with you so that the healthcare team can see exactly what was taken. Symptoms of overdose depend on the pharmacology of the active substance and can include exaggerated therapeutic effects as well as adverse reactions. Do not try to induce vomiting or take other countermeasures without professional guidance.

When to Seek Emergency Care

Call your local emergency number (such as 112 in the EU, 911 in North America, or 999 in the UK) if someone has taken a large overdose and is unconscious, having a seizure, struggling to breathe, or showing signs of a severe allergic reaction. Do not wait to see if symptoms improve. See the emergency numbers page for country-specific contacts.

What Are the Side Effects of OLVION?

Quick Answer: Like all medicines, OLVION may cause side effects, although not everyone experiences them. Most side effects are mild and improve over time or with dose adjustment. Seek urgent medical attention for any signs of a severe allergic reaction, and report unusual or persistent symptoms to your doctor or pharmacist.

Prescription medicines are authorised only when regulators have determined that their expected benefits outweigh their known risks in the approved indication. Nevertheless, every medicine, including OLVION, can cause side effects (adverse reactions). Most are mild, reversible and manageable; some are more serious but rare. In regulatory documents, side effects are grouped by how often they occur in people who take the medicine, using a standard international convention.

The frequency categories used throughout the European Union, and familiar to most patients through the Patient Information Leaflet, are:

Very Common

May affect more than 1 in 10 people

  • Mild gastrointestinal symptoms such as nausea, abdominal discomfort or changes in bowel habit may occur with many oral medicines
  • Headache and fatigue are frequently reported general symptoms during any new drug therapy

Common

May affect up to 1 in 10 people

  • Dizziness, drowsiness or mild changes in sleep pattern
  • Skin reactions such as rash or itching
  • Changes in appetite or mild weight change

Uncommon

May affect up to 1 in 100 people

  • More pronounced gastrointestinal reactions, including vomiting
  • Mood changes, including low mood or anxiety
  • Changes in laboratory tests (for example, liver or kidney function tests)

Rare

May affect up to 1 in 1,000 people

  • Severe allergic reactions including anaphylaxis
  • Severe skin reactions requiring medical attention
  • Serious blood, liver or kidney disorders

Very Rare / Not Known

Cannot be estimated from the available data

  • Adverse events reported only in isolated cases after marketing
  • Unusual or unexpected reactions — report these so that pharmacovigilance systems can track them

The categories and example symptoms above are intentionally generic. For the authoritative, product-specific list of adverse reactions for OLVION, consult the Patient Information Leaflet inside your pack and, if needed, the full Summary of Product Characteristics for your country. Those documents reflect the cumulative evidence from clinical trials and post-marketing surveillance and are updated as new information becomes available.

Certain patterns of side effects warrant particular attention. Gastrointestinal side effects (nausea, abdominal pain, altered bowel habit) are often most pronounced at the start of treatment and frequently settle within the first one to two weeks. Taking the tablet with food, when permitted, can sometimes reduce stomach upset. Headache, dizziness and fatigue also tend to lessen as the body adjusts. Persistent, severe or worsening symptoms, however, should always be discussed with your doctor or pharmacist, who can advise whether dose adjustment, temporary interruption, or a different treatment is appropriate.

Skin reactions deserve special caution. Mild itching or a transient rash is often benign, but any rapidly spreading rash, rash involving mucous membranes (eyes, mouth, genitals), blistering, skin peeling, or rash accompanied by fever, swollen glands or feeling unwell can be a sign of a serious reaction. Stop OLVION and seek urgent medical assessment if such symptoms appear.

When to Seek Medical Attention

Contact your doctor or go to the nearest emergency department immediately if you experience any of the following after taking OLVION: swelling of the face, lips, tongue or throat; difficulty breathing or swallowing; widespread or severe rash, blistering or skin peeling; yellowing of the skin or eyes (jaundice); unusual bruising or bleeding; chest pain, fainting or a racing or irregular heartbeat; or any other symptom that feels serious or unusual. Do not wait for your next routine appointment.

Reporting Side Effects

If you experience any side effect from OLVION, even one that is not listed in the Patient Information Leaflet, report it to your doctor, pharmacist or nurse. You can also report side effects directly to the relevant national pharmacovigilance system (for example, the MHRA Yellow Card scheme in the UK, the FDA MedWatch programme in the United States, or the EudraVigilance system in the European Union). By reporting side effects, you help provide more information on the safety of OLVION and contribute to the continuous monitoring that protects all patients.

How Should You Store OLVION?

Quick Answer: Store OLVION in its original pack, protected from light and moisture. Keep tablets out of the sight and reach of children. Do not use after the expiry date printed on the pack. Follow any specific temperature instructions in the Patient Information Leaflet, and never dispose of unused medicine in wastewater or household rubbish.

Proper storage is essential for maintaining the quality, potency and safety of OLVION throughout its shelf life. Film-coated tablets are generally stable at ordinary room temperature, but they are still sensitive to excess moisture, high temperatures and direct light, all of which can accelerate chemical degradation or alter the physical properties of the tablet.

Follow these general storage principles for OLVION, in addition to any product-specific guidance in the Patient Information Leaflet:

  • Keep in the original pack: The blister or bottle has been designed to protect the tablets from moisture and light. Do not transfer OLVION tablets into unmarked pill organisers long-term unless your pharmacist confirms this is appropriate for this medicine.
  • Store at the recommended temperature: Unless the PIL specifies a specific temperature (such as “do not store above 25 °C” or “store in a refrigerator”), keep the pack in a cool, dry place at normal room temperature.
  • Avoid humid locations: Bathrooms and kitchens are often more humid than the rest of the home. A bedroom drawer or cupboard is usually a better choice for most tablets.
  • Protect from light: Keep the medicine in its outer carton to protect from direct sunlight and strong artificial light.
  • Do not freeze: Unless explicitly recommended, avoid freezing tablets, as temperature extremes can affect stability.
  • Keep out of reach of children: Store OLVION in a location that is safely out of sight and reach of children. If there is any possibility of accidental ingestion, a lockable storage box is strongly recommended.
  • Check the expiry date: Do not use OLVION after the expiry date stated on the pack (commonly shown after “EXP” or “Exp. date”). The expiry date usually refers to the last day of that month.
  • Inspect the tablets before each dose: If the tablets look discoloured, broken, cracked, stuck together or otherwise abnormal, do not take them and consult your pharmacist.
  • Dispose of unused medicine safely: Never throw any medicines away via wastewater (such as flushing down the toilet) or household waste. Ask your pharmacist how to dispose of medicines you no longer use; many countries operate a pharmacy take-back scheme.

When travelling with OLVION, keep it in its original labelled pack along with a copy of your prescription. For international travel, check the regulations of your destination country regarding prescription medicines. If flying, keep the medicine in your hand luggage where temperatures are more stable and the risk of loss is lower. Avoid leaving OLVION in a parked car, on a sunny windowsill, or in any location where temperatures may fluctuate significantly.

What Does OLVION Contain?

Quick Answer: Each OLVION film-coated tablet contains 50 mg of the active substance olvion, together with a number of pharmaceutical excipients that support manufacturing and stability. The complete list of ingredients for your specific product is printed in the Patient Information Leaflet inside the pack.

Knowing exactly what your medicine contains is particularly important for people with allergies, food intolerances or dietary restrictions. Every authorised prescription medicine is required to list both its active substance and all excipients in the Patient Information Leaflet and Summary of Product Characteristics.

Active Ingredient

The active substance in OLVION is olvion. Each film-coated tablet contains 50 mg of olvion. The active substance is the pharmacologically active component that produces the therapeutic effect for which OLVION has been prescribed.

Inactive Ingredients (Excipients)

In addition to the active substance, film-coated tablets contain a range of inactive ingredients. These have no therapeutic effect themselves but are essential for producing a tablet that is stable, uniform, easy to swallow and reliable in its release of the active substance. Typical excipient categories found in film-coated tablets are summarised below. The exact list for OLVION is given in the Patient Information Leaflet.

Typical Excipient Categories in Film-Coated Tablets
Excipient Category Examples Role
Fillers / diluents Microcrystalline cellulose, lactose monohydrate, mannitol Provide tablet bulk so that small active doses can be handled
Binders Povidone, hydroxypropyl cellulose Hold the tablet together during manufacture
Disintegrants Croscarmellose sodium, sodium starch glycolate Help the tablet break apart in the gastrointestinal tract
Lubricants / glidants Magnesium stearate, colloidal silicon dioxide Prevent sticking during tablet compression
Coating components Hypromellose, titanium dioxide, macrogol, colouring agents Form the thin film around the tablet for protection and appearance

Appearance and Pack Sizes

OLVION is supplied as a film-coated tablet containing 50 mg of the active substance. The shape, colour and markings (including any score lines) are specified in the Patient Information Leaflet and should be checked each time a new pack is dispensed, so that patients can recognise their medicine. Pack sizes vary by country and by the expected duration of treatment; not all pack sizes may be marketed in every country.

Marketing Authorisation Holder and Manufacturer

The marketing authorisation holder for OLVION is the pharmaceutical company responsible for the medicine’s regulatory status and pharmacovigilance in each country where it is authorised. The manufacturer may be the same company or a contract manufacturing organisation acting on its behalf. The full name and address of both the marketing authorisation holder and the manufacturer are printed on the outer carton and in the Patient Information Leaflet, along with contact information for reporting suspected adverse reactions.

Frequently Asked Questions About OLVION

OLVION is a prescription-only oral medicine supplied as 50 mg film-coated tablets. It is used only for the specific medical condition for which your doctor has prescribed it. Because OLVION is a prescription medication, the exact therapeutic indication, treatment duration and expected outcomes depend on your individual diagnosis. Always read the Patient Information Leaflet that comes with your pack and follow the instructions given by your doctor and pharmacist.

Take OLVION exactly as your doctor has prescribed. Swallow each 50 mg film-coated tablet whole with a full glass of water. Do not crush, chew or split the tablet unless your doctor or pharmacist specifically tells you that it is safe to do so. The number of tablets per day, the timing with or without food, and the total duration of treatment are individualised; they are stated on the prescription label and in the Patient Information Leaflet.

If you forget a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your normal schedule. Never double up to make up for a missed dose. Using a pill organiser, phone reminder, or linking the dose to a regular daily activity can help you remember. If you are unsure what to do, call your pharmacist for personalised advice.

Whether it is safe to drink alcohol while taking OLVION depends on the active substance and your individual circumstances. In general, alcohol can increase the risk of side effects such as drowsiness, dizziness and stomach irritation with many prescription medicines, and can interact with specific drug classes in more serious ways. It is sensible to ask your doctor or pharmacist whether any restriction on alcohol applies to your treatment, and to read the Patient Information Leaflet for product-specific advice.

No. Do not stop OLVION earlier than your doctor has planned, even if you feel better. Stopping a prescription medicine prematurely can allow the underlying condition to return, can reduce the overall effectiveness of the treatment (particularly for infections), and, for some drug classes, can cause withdrawal effects. If you want to stop OLVION for any reason, talk to your doctor first so that a safe plan can be made — this may involve gradual dose reduction rather than an abrupt stop.

If you are pregnant, think you may be pregnant, are planning a pregnancy, or are breastfeeding, talk to your doctor before taking OLVION. Prescription medicines vary widely in their safety profile during pregnancy and lactation, and the decision must always be made individually, weighing the benefit to the mother against any theoretical or known risk to the baby. Never start or stop OLVION on your own during pregnancy or breastfeeding — ask a healthcare professional.

Never throw unused medicines away in wastewater (for example, by flushing down the toilet) or in household rubbish. Instead, return unused or expired OLVION to your community pharmacy, where many countries operate a medicines take-back scheme. Proper disposal protects the environment and prevents accidental ingestion by children, pets or other household members.

References

  1. European Medicines Agency (EMA). Guideline on Summary of Product Characteristics (SmPC). Rev. 2. Committee for Medicinal Products for Human Use. Available at: EMA product information.
  2. U.S. Food and Drug Administration (FDA). Prescription Drug Labeling – Physician Labeling Rule (PLR) Requirements. FDA Center for Drug Evaluation and Research. 2024.
  3. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Guideline E2E: Pharmacovigilance Planning. 2024.
  4. World Health Organization (WHO). Promoting Rational Use of Medicines. WHO Policy Perspectives on Medicines. 2023. Available at: WHO medicines selection.
  5. British National Formulary (BNF). Joint Formulary Committee. National Institute for Health and Care Excellence (NICE). Updated continuously.
  6. Joint Commission on Pharmacy Practitioners. Pharmacists’ Patient Care Process. 2024.
  7. Aronson JK, Ferner RE. Joining the DoTS: New Approach to Classifying Adverse Drug Reactions. BMJ. 2003;327(7425):1222–1225. doi:10.1136/bmj.327.7425.1222.
  8. World Health Organization (WHO). Safety of Medicines – A Guide to Detecting and Reporting Adverse Drug Reactions. WHO. 2023.
  9. European Medicines Agency (EMA). Good Pharmacovigilance Practices (GVP). Module VI – Collection, Management and Submission of Reports of Suspected Adverse Reactions. 2024.
  10. National Institute for Health and Care Excellence (NICE). Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes. NICE Guideline NG5. 2023.

About Our Medical Team

All content on iMedic is created and reviewed by qualified medical professionals following international evidence-based guidelines. Our editorial process ensures accuracy, currency, and clinical relevance.

Medical Content Team

Specialists in clinical pharmacology, internal medicine and patient education with extensive experience in translating regulatory-authority prescribing information into plain-language patient guides.

Medical Review Board

Independent panel of board-certified physicians who verify all medical claims against current evidence and international guidelines (WHO, EMA, FDA, BNF, ICH).

Editorial Standards

All content follows the GRADE evidence framework and is based on regulatory-authority prescribing information and Level 1A evidence from systematic reviews where available.

Independence

iMedic receives no pharmaceutical company funding or sponsorship. All content is editorially independent, ensuring unbiased medical information for patients and caregivers.